Downstream Processing Market Report: Trends, Forecast and Competitive Analysis to 2030

Downstream Processing Trends and Forecast

The future of the global downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets. The global downstream processing market is expected to reach an estimated $53.6 billion by 2030 with a CAGR of 13.2% from 2024 to 2030. The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

A more than 150-page report is developed to help in your business decisions.

Downstream Processing by Segment

The study includes a forecast for the global downstream processing by technique, product, application, end use industry, and region.

Downstream Processing Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

• Purification
• Solid-Liquid Separation
• Clarification/Concentration

Downstream Processing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Chromatography Columns & Resins
• Filters
• Membrane Adsorbers
• Single-Use Products
• Others

Downstream Processing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Monoclonal Antibody Production
• Vaccine Production
• Insulin Production
• Immunoglobulin Production
• Erythropoietin Production
• Others

Downstream Processing Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Biopharmaceutical Manufacturers
• Contract Manufacturing Organizations
• Otherss

Downstream Processing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Downstream Processing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies downstream processing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the downstream processing companies profiled in this report include-

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

Downstream Processing Market Insights

Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Within this market, biopharmaceutical manufacturers will remain the largest segment due to rising need for biopharmaceuticals among the elderly demographic.

APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Features of the Global Downstream Processing Market

Market Size Estimates: Downstream processing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Downstream processing market size by various segments, such as by technique, product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Downstream processing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technique, product, application, end use industry, and regions for the downstream processing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the downstream processing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the downstream processing market size?

Answer: The global downstream processing market is expected to reach an estimated $53.6 billion by 2030.

Q2. What is the growth forecast for downstream processing market?

Answer: The global downstream processing market is expected to grow with a CAGR of 13.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the downstream processing market?

Answer: The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

Q4. What are the major segments for downstream processing market?

Answer: The future of the downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets.

Q5. Who are the key downstream processing market companies?

Answer: Some of the key downstream processing companies are as follows.

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

Q6. Which downstream processing market segment will be the largest in future?

Answer: Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Q7. In downstream processing market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the downstream processing market by technique (purification, solid-liquid separation, and clarification/concentration), product (chromatography columns & resins, filters, membrane adsorbers, single-use products, and others), application (monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and others), end use industry (biopharmaceutical manufacturers, contract manufacturing organizations, and otherss), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?